Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Torre-Muir syndrome].

M Hagedorn1, T Bauknecht, R Russwurm

  • 1Universitäts-Hautklinik Freiburg im Breisgau.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|November 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New injectable self-assembled hydrogels that promote angiogenesis through a bioactive degradation product.

Acta biomaterialia·2020
Same author

Electric field-driven coherent spin reorientation of optically generated electron spin packets in InGaAs.

Physical review letters·2012
Same author

Comparative cryobiological traits and requirements for gametes and gonadal tissues collected from wildlife species.

Theriogenology·2012
Same author

Left-right asymmetry in embryonic development and breast cancer: common molecular determinants?

Current medicinal chemistry·2011
Same author

Ovarian adenocarcinomas express members of different cytokine pathways - analysis and quantification of transcripts from the tgf-alpha and m-csf fms pathways and the transcription factor cjun.

International journal of oncology·2011
Same author

A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2010
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

Torre-Muir syndrome involves multiple skin and internal tumors, including sebaceous gland cancers. This case highlights the syndrome's varied tumor locations, primarily in the digestive and urinary systems.

Area of Science:

  • Oncology
  • Dermatology
  • Genetics

Background:

  • Torre-Muir syndrome is a rare hereditary cancer predisposition syndrome.
  • It is characterized by the association of Muir-Torre syndrome (MTS) with other visceral malignancies.

Observation:

  • This report details a case of Torre-Muir syndrome in a female patient.
  • The case illustrates diverse tumor manifestations and localizations.

Findings:

  • The syndrome presents with multiple primary cutaneous and extracutaneous carcinomas.
  • Visceral adenocarcinomas are predominantly observed in the gastrointestinal and urogenital tracts.
  • Sebaceous neoplasias are a key feature of the syndrome.

Implications:

Related Experiment Videos

  • Understanding Torre-Muir syndrome is crucial for early diagnosis and management of associated cancers.
  • This case emphasizes the importance of thorough investigation in patients with multiple neoplasms.
  • Further research into the genetic underpinnings of Torre-Muir syndrome can improve risk stratification and targeted therapies.